FIPP Final Exam 2026 Study Guide & Practice Test Bank |
400Real Exam Questions and Correct Verified Answers/
Already Graded A+ (Brand New!!)
,1. Which term describes the amount of medication physically present
on the pharmacy shelf across equivalent NDCs?
A. Economic order quantity
B. Balance on hand
C. Reorder quantity
D. Safety stock
Answer: _B. Balance on hand**_
Rationale: Balance on hand represents the quantity of medication
currently available in inventory.
2. A pharmacy's reorder point is best described as:
A. The maximum quantity allowed in inventory
B. The quantity dispensed during one month
C. The inventory level at which another order should be triggered
D. The quantity returned to the wholesaler
Answer: _C. The inventory level at which another order should be
triggered**_
Rationale: The reorder point identifies when inventory has fallen
sufficiently to initiate replenishment.
,3. Which inventory concept represents the maximum quantity an
automated system should maintain?
A. Minimum stock
B. Maximum reorder point
C. Safety stock
D. Average daily usage
Answer: _B. Maximum reorder point**_
Rationale: A maximum reorder point establishes the upper inventory
level the system seeks to maintain.
4. Which pharmacy area has experienced substantial growth because of
the increasing use of complex biologic and high-cost therapies?
A. Specialty pharmacy
B. Nuclear pharmacy only
C. Compounding pharmacy only
D. Veterinary pharmacy
Answer: _A. Specialty pharmacy**_
, Rationale: Specialty pharmacy manages many complex, high-cost, and
specialized therapies.
5. A medication error that reaches the patient but causes no harm is
generally classified as:
A. Adverse drug reaction
B. No-harm medication error
C. Sentinel event
D. Contraindication
Answer: _B. No-harm medication error**_
Rationale: An error may reach a patient without producing harm.
6. Which term describes harm associated with the use of a medication,
whether or not the medication was used appropriately?
A. Adverse drug event
B. Near miss
C. Formulary exception
D. Therapeutic duplication
Answer: _A. Adverse drug event**_
400Real Exam Questions and Correct Verified Answers/
Already Graded A+ (Brand New!!)
,1. Which term describes the amount of medication physically present
on the pharmacy shelf across equivalent NDCs?
A. Economic order quantity
B. Balance on hand
C. Reorder quantity
D. Safety stock
Answer: _B. Balance on hand**_
Rationale: Balance on hand represents the quantity of medication
currently available in inventory.
2. A pharmacy's reorder point is best described as:
A. The maximum quantity allowed in inventory
B. The quantity dispensed during one month
C. The inventory level at which another order should be triggered
D. The quantity returned to the wholesaler
Answer: _C. The inventory level at which another order should be
triggered**_
Rationale: The reorder point identifies when inventory has fallen
sufficiently to initiate replenishment.
,3. Which inventory concept represents the maximum quantity an
automated system should maintain?
A. Minimum stock
B. Maximum reorder point
C. Safety stock
D. Average daily usage
Answer: _B. Maximum reorder point**_
Rationale: A maximum reorder point establishes the upper inventory
level the system seeks to maintain.
4. Which pharmacy area has experienced substantial growth because of
the increasing use of complex biologic and high-cost therapies?
A. Specialty pharmacy
B. Nuclear pharmacy only
C. Compounding pharmacy only
D. Veterinary pharmacy
Answer: _A. Specialty pharmacy**_
, Rationale: Specialty pharmacy manages many complex, high-cost, and
specialized therapies.
5. A medication error that reaches the patient but causes no harm is
generally classified as:
A. Adverse drug reaction
B. No-harm medication error
C. Sentinel event
D. Contraindication
Answer: _B. No-harm medication error**_
Rationale: An error may reach a patient without producing harm.
6. Which term describes harm associated with the use of a medication,
whether or not the medication was used appropriately?
A. Adverse drug event
B. Near miss
C. Formulary exception
D. Therapeutic duplication
Answer: _A. Adverse drug event**_
